Novel interactions between FOXP2 and PAX6: Implications for neural development and autism spectrum disorders.

Scientists studied how two important brain development genes (FOXP2 and PAX6) interact with each other. Both genes are linked to autism when they don't work properly. The research found that these genes compete with each other when trying to control other genes, with PAX6 usually winning this competition. This discovery helps explain how these genes might work together during brain development and could provide insights into what goes wrong in autism.

This molecular study investigated protein interactions between FOXP2 and PAX6, two transcription factors crucial for neural development and linked to autism spectrum disorders. Using fluorescence anisotropy and molecular docking techniques, researchers found that FOXP2's forkhead domain directly interacts with both PAX6 domains with low micromolar binding affinities. Notably, PAX6 domains could displace FOXP2 from DNA binding sites despite FOXP2's stronger intrinsic DNA affinity, demonstrating competitive dominance by PAX6. The H3 helix of FOXP2's forkhead domain was identified as central to assembly, contributing to both DNA and protein interfaces.

This asymmetric interplay suggests novel mechanisms for transcriptional regulation during neurodevelopment, providing molecular insights into how these autism-linked genes may interact.

While providing molecular insights into FOXP2-PAX6 interactions, translation to clinical practice requires further research. The competitive binding mechanisms identified could inform future therapeutic targets for neurodevelopmental interventions, but direct clinical applications remain distant.

This is an in vitro molecular study using isolated protein domains. The clinical relevance to autism spectrum disorders is theoretical, as no patient samples or functional outcomes were examined. Sample size and statistical methods are not reported.

FOXP2 and PAX6 are transcription factors essential for neural development, with mutations in both linked to autism spectrum disorders (ASDs). Their DNA-binding domains include a forkhead domain (FHD) for FOXP2 and a paired domain (PD) plus homeodomain (HD) for PAX6. We investigated whether the FOXP2 FHD interacts directly with PAX6 PD or HD, and how such interactions influence DNA binding. Fluorescence anisotropy showed that all three domains bind specifically to their respective DNA targets with similar affinities.

The FOXP2 FHD also interacts directly with both PAX6 PD and HD, with low micromolar binding affinities. Despite its stronger intrinsic DNA affinity, the FHD was displaced from its target DNA by both PAX6 domains, suggesting that protein-protein interactions can override DNA affinity under competitive conditions. In contrast, FOXP2 could not displace PD or HD from their DNA targets. Molecular docking supported these findings: DNA-protein interfaces were largely unchanged by the second protein, but protein-protein interfaces were strongly influenced by DNA occupancy.

The H3 helix of FHD was identified as a central point for assembly, contributing to both DNA and protein interfaces. When FHD was bound to DNA, H3 was occupied, forcing PD or HD to dock at alternative, less optimal sites. HD maintained stronger contacts in these rearranged states, consistent with its greater competitive strength. This asymmetric interplay indicates competitive dominance by PAX6 and suggests mechanisms that could underlie transcriptional regulation in neurodevelopment.